+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
IVD Reagents Market - Global Forecast 2026-2032- Product Image
IVD Reagents Market - Global Forecast 2026-2032- Product Image
Sale

IVD Reagents Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090088
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The IVD Reagents Market is projected to reach USD 63.27 Billion in 2026. It is expected to continue growing at a CAGR of 7.98%, reaching USD 99.85 Billion by 2032.

IVD Reagents: Executive Overview

In vitro diagnostic (IVD) reagents support the detection, characterization, and monitoring of disease through laboratory and near-patient testing. Their role spans clinical chemistry, immunoassay, molecular diagnostics, hematology, microbiology, pathology, and emerging multi-analyte workflows. Market development is shaped by demand for faster turnaround, dependable analytical performance, improved laboratory efficiency, and broader access to testing across hospitals, reference laboratories, physician offices, and decentralized care settings.

Workflow Integration Is Reshaping IVD Reagents

The IVD reagent landscape is shifting from stand-alone assays toward integrated workflows that connect sample preparation, testing, interpretation, quality control, and reporting. Laboratories increasingly prioritize automation, interoperability, reagent standardization, and simplified handling to reduce errors and support constrained staffing environments. At the same time, decentralized testing is expanding the need for stable, easy-to-use reagent formats that can deliver consistent results outside traditional laboratories. Regulatory scrutiny, supply continuity, sustainability, and evidence of clinical utility are becoming increasingly important alongside analytical performance.

Artificial Intelligence Is Increasing the Value of Reagent Data

Artificial intelligence is influencing IVD reagent workflows primarily through data interpretation, quality monitoring, operational optimization, and clinical decision support. Machine-learning tools can help identify anomalous results, improve reflex-testing pathways, prioritize workloads, and support interpretation of complex molecular, pathology, and multiplex datasets. These benefits depend on representative training data, transparent validation, secure integration with laboratory information systems, and clear responsibility for clinical decisions. AI therefore complements, rather than replaces, the need for robust reagent design, traceability, calibration, and ongoing quality assurance.

Regional Insights Across Six IVD Reagent Landscapes

North America is characterized by advanced laboratory automation, established reimbursement and accreditation structures, and strong adoption of molecular and specialty testing. Latin America presents opportunities linked to expanding diagnostic access, while procurement constraints, uneven infrastructure, and import dependence remain practical considerations. Europe emphasizes regulatory compliance, cross-border quality expectations, sustainability, and integration with public health systems. The Middle East is investing in healthcare modernization and centralized laboratory capacity, with demand shaped by specialist services and localization objectives. Africa shows significant unmet need for accessible, durable, and decentralized testing, particularly where logistics and laboratory infrastructure are limited. Asia-Pacific combines sophisticated laboratory markets with rapidly expanding testing access, manufacturing capabilities, and diverse regulatory environments.

Group-Level Priorities: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries are balancing urban tertiary-care capacity with the need to extend reliable diagnostics to distributed populations, making interoperability, affordability, and service support important. BRICS members reflect varied healthcare systems but share priorities around domestic capability, resilient procurement, and broader access to essential testing. The European Union places strong emphasis on harmonized regulation, performance evidence, data governance, and sustainable healthcare operations. G7 markets generally prioritize advanced diagnostics, laboratory productivity, cybersecurity, and integration with mature health systems. GCC countries are emphasizing healthcare modernization, centralized expertise, and local capacity building. NATO members, considered collectively, also face requirements for resilient medical supply chains, preparedness, and dependable diagnostic capacity during emergencies.

Country-Level Signals Across Fifteen Priority Markets

Australia combines geographically dispersed care with strong clinical governance, increasing the value of decentralized and interoperable testing. Brazil and Mexico are shaped by large and diverse healthcare systems, regional access differences, and public-sector procurement complexity. Canada and the United States emphasize laboratory automation, advanced molecular testing, quality systems, and health-data integration. China is strengthening domestic diagnostic capabilities while supporting broad hospital and public-health applications. France, Germany, Italy, Spain, and the United Kingdom operate within sophisticated European regulatory and healthcare environments, with attention to evidence, efficiency, and sustainability. India’s diverse care infrastructure supports demand for scalable, cost-conscious testing formats. Japan and South Korea emphasize precision, automation, quality, and technology-enabled laboratory operations. Russia’s diagnostic environment is influenced by supply resilience, localization, and continuity of access under changing trade conditions.

Actions for Leaders Building Resilient IVD Reagent Portfolios

Industry leaders should prioritize reagent platforms that combine analytical reliability with simple workflows, automation compatibility, and flexible deployment across centralized and decentralized settings. Supply resilience can be strengthened through qualified dual sourcing, regional inventory strategies, validated transport conditions, and transparent lot traceability. Product development should be guided by clearly documented clinical use cases, evidence generated across relevant populations, and regulatory requirements in each target jurisdiction. Leaders should also establish responsible AI governance, including validation, monitoring, cybersecurity, and human oversight. Partnerships with laboratories, health systems, distributors, and public-health agencies can improve implementation, training, service coverage, and real-world performance.

Research Methodology for the IVD Reagents Executive Summary

This executive summary uses a structured synthesis of the IVD reagents domain, relevant diagnostic workflows, healthcare delivery settings, regulatory considerations, technology developments, and the specified geographic groupings. Insights are organized thematically across product use, laboratory operations, artificial intelligence, regional conditions, and implementation priorities. The assessment emphasizes qualitative, verifiable industry drivers and constraints rather than market estimates, market sizing, market shares, or forecasts. Regional, group, and country observations are framed as contextual signals and should be validated against current regulatory guidance, procurement policies, clinical evidence, and local operating conditions before strategic decisions are made.

Conclusion: Reliability, Access, and Integration Define Progress

The IVD reagents landscape is advancing toward connected, automated, data-enabled, and more distributed diagnostic workflows. Success will depend on maintaining analytical integrity while improving usability, supply resilience, interoperability, and access across highly diverse healthcare environments. Artificial intelligence can increase the value of reagent-generated data, but only when supported by high-quality inputs, strong governance, and accountable clinical workflows. Leaders that align innovation with evidence, regulatory discipline, operational practicality, and regional needs will be best positioned to contribute to more timely and dependable diagnosis.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. IVD Reagents Market, by Product
7.1. Introduction
7.2. Kits
7.3. Reagents
7.3.1. Biochemical Reagents
7.3.2. Immunoassay Reagents
7.3.3. Molecular Diagnostic Reagents
8. IVD Reagents Market, by Technology
8.1. Introduction
8.2. Clinical Chemistry
8.3. Immunoassays
8.4. Microarray Technology
8.5. Next Generation Sequencing
8.6. Polymerase Chain Reaction
9. IVD Reagents Market, by Test Type
9.1. Introduction
9.2. Laboratory Tests
9.3. Point-of-Care tests
10. IVD Reagents Market, by Indication
10.1. Introduction
10.2. Cardiology
10.3. Drug Monitoring & Testing
10.4. Endocrinology
10.5. Infectious Diseases
10.6. Oncology
11. IVD Reagents Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Diagnostic Laboratories
11.4. Hospitals
12. IVD Reagents Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. IVD Reagents Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. IVD Reagents Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Agilent Technologies, Inc.
16.3. Becton, Dickinson and Company
16.4. Bio-Rad Laboratories, Inc.
16.5. bioMérieux S.A.
16.6. Danaher Corporation
16.7. DiaSorin S.p.A.
16.8. Eli Lilly and Company
16.9. F. Hoffmann-La Roche Ltd
16.10. GenScript Biotech Corporation
16.11. H.U. Group Holdings, Inc.
16.12. Hologic, Inc.
16.13. Hycor Biomedical LLC
16.14. Illumina, Inc.
16.15. Medical & Biological Laboratories Co., Ltd. by JSR Life Sciences
16.16. Merck KGaA
16.17. Mindray Medical International Limited
16.18. PerkinElmer Inc.
16.19. QIAGEN N.V.
16.20. Quidel Corporation
16.21. Rekom Biotech S.L.
16.22. Siemens Healthineers
16.23. Sysmex Corporation
16.24. Theradiag
16.25. Thermo Fisher Scientific Inc.
16.26. Tosoh Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global IVD Reagents Market, Years Considered for the Study
FIGURE 2. Global IVD Reagents Market, Research Design
FIGURE 3. Global IVD Reagents Market, Research Framework
FIGURE 4. Global IVD Reagents Market, Data Triangulation
FIGURE 5. Global IVD Reagents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global IVD Reagents Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global IVD Reagents Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global IVD Reagents Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global IVD Reagents Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global IVD Reagents Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 11. Global IVD Reagents Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global IVD Reagents Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global IVD Reagents Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global IVD Reagents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global IVD Reagents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global IVD Reagents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global IVD Reagents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global IVD Reagents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global IVD Reagents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global IVD Reagents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global IVD Reagents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global IVD Reagents Market Segmentation & Coverage
TABLE 2. Global IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 3. Global IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Biochemical Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Biochemical Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Biochemical Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Immunoassay Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Immunoassay Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Immunoassay Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Molecular Diagnostic Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Molecular Diagnostic Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Molecular Diagnostic Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 20. Global Clinical Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Clinical Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Clinical Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Microarray Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Microarray Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Microarray Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 36. Global Laboratory Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Laboratory Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Laboratory Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Point-of-Care tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Point-of-Care tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Point-of-Care tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 43. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Drug Monitoring & Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Drug Monitoring & Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Drug Monitoring & Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Endocrinology Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Endocrinology Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Endocrinology Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. North America IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. North America IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 78. North America IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 79. North America IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 80. North America IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 81. North America IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 82. North America IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Latin America IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Latin America IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 85. Latin America IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 86. Latin America IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 87. Latin America IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 88. Latin America IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 89. Latin America IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Europe IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Europe IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 92. Europe IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 93. Europe IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 94. Europe IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 95. Europe IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 96. Europe IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Middle East IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Middle East IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 99. Middle East IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 100. Middle East IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 101. Middle East IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 102. Middle East IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 103. Middle East IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Africa IVD Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Africa IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 106. Africa IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 107. Africa IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 108. Africa IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 109. Africa IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 110. Africa IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Global IVD Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. ASEAN IVD Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. ASEAN IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 114. ASEAN IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 115. ASEAN IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 116. ASEAN IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 117. ASEAN IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 118. ASEAN IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. GCC IVD Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. GCC IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 121. GCC IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 122. GCC IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 123. GCC IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 124. GCC IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 125. GCC IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. European Union IVD Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. European Union IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 128. European Union IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 129. European Union IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 130. European Union IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 131. European Union IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 132. European Union IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. BRICS IVD Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. BRICS IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 135. BRICS IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 136. BRICS IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 137. BRICS IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 138. BRICS IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 139. BRICS IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. G7 IVD Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. G7 IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 142. G7 IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 143. G7 IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 144. G7 IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 145. G7 IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 146. G7 IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. NATO IVD Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. NATO IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 149. NATO IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 150. NATO IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 151. NATO IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 152. NATO IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 153. NATO IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Global IVD Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. United States IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 156. United States IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 157. United States IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 158. United States IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 159. United States IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 160. United States IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 161. United States IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Canada IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 163. Canada IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 164. Canada IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 165. Canada IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 166. Canada IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 167. Canada IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 168. Canada IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Mexico IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 170. Mexico IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 171. Mexico IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 172. Mexico IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 173. Mexico IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 174. Mexico IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 175. Mexico IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Brazil IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 177. Brazil IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 178. Brazil IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 179. Brazil IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 180. Brazil IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 181. Brazil IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 182. Brazil IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. United Kingdom IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 184. United Kingdom IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 185. United Kingdom IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 186. United Kingdom IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 187. United Kingdom IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 188. United Kingdom IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 189. United Kingdom IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Germany IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 191. Germany IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 192. Germany IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 193. Germany IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 194. Germany IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 195. Germany IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 196. Germany IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. France IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 198. France IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 199. France IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 200. France IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 201. France IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 202. France IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 203. France IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Russia IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 205. Russia IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 206. Russia IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 207. Russia IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Russia IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 209. Russia IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 210. Russia IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Italy IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 212. Italy IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 213. Italy IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 214. Italy IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 215. Italy IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 216. Italy IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 217. Italy IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Spain IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 219. Spain IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 220. Spain IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 221. Spain IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 222. Spain IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 223. Spain IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 224. Spain IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. China IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 226. China IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 227. China IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 228. China IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 229. China IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 230. China IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 231. China IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. India IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 233. India IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 234. India IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 235. India IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 236. India IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 237. India IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 238. India IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. Japan IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 240. Japan IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 241. Japan IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 242. Japan IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 243. Japan IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 244. Japan IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 245. Japan IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Australia IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 247. Australia IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 248. Australia IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 249. Australia IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 250. Australia IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 251. Australia IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 252. Australia IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. South Korea IVD Reagents Market Size, 2017-2032 (USD Million)
TABLE 254. South Korea IVD Reagents Market Size, by Product, 2017-2032 (USD Million)
TABLE 255. South Korea IVD Reagents Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 256. South Korea IVD Reagents Market Size, by Technology, 2017-2032 (USD Million)
TABLE 257. South Korea IVD Reagents Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 258. South Korea IVD Reagents Market Size, by Indication, 2017-2032 (USD Million)
TABLE 259. South Korea IVD Reagents Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Global IVD Reagents Market Share, by Key Player, 2025
TABLE 261. Global IVD Reagents Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux S.A.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GenScript Biotech Corporation
  • H.U. Group Holdings, Inc.
  • Hologic, Inc.
  • Hycor Biomedical LLC
  • Illumina, Inc.
  • Medical & Biological Laboratories Co., Ltd. by JSR Life Sciences
  • Merck KGaA
  • Mindray Medical International Limited
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Quidel Corporation
  • Rekom Biotech S.L.
  • Siemens Healthineers
  • Sysmex Corporation
  • Theradiag
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation

Related Topics

Related Reports

Clinical IVD Reagents Market - Global Forecast 2026-2032 - Product Image

Clinical IVD Reagents Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
IVD Reagents Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Application, End User, Technology - Product Image

IVD Reagents Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Application, End User, Technology

  • Report
  • 160 Pages
  • Global
From
IVD Contract Manufacturing Service Market - Global Forecast 2026-2032 - Product Image

IVD Contract Manufacturing Service Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
South Africa IVD Centralized Diagnostics Market (By Segment - Immunoassay, Clinical Chemistry, Coagulation, Hematology, Urinalysis, Rest of Centralized Diagnostics), Company Share Analysis, Market Dynamics and Recent Developments - Forecast to 2032 - Product Image

South Africa IVD Centralized Diagnostics Market (By Segment - Immunoassay, Clinical Chemistry, Coagulation, Hematology, Urinalysis, Rest of Centralized Diagnostics), Company Share Analysis, Market Dynamics and Recent Developments - Forecast to 2032

  • Report
  • 115 Pages
  • South Africa
From
IVD Contract Manufacturing - Global Strategic Business Report - Product Image

IVD Contract Manufacturing - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.